MedPath
Found 2 clinical trials|View Analysis
Sort by:

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Phase 1
Recruiting
Conditions
Non-hodgkin Lymphoma
Plasma Cell Myeloma
Leukemia, Myeloid, Acute
Leukemia, Lymphoblastic, Acute, L2
Myelodysplastic Syndromes
Leukemia, Lymphoblastic, Acute, L1
Interventions
First Posted Date
2021-08-13
Last Posted Date
2023-08-01
Lead Sponsor
Melbourne Health
Target Recruit Count
18
Registration Number
NCT05005299
Locations
🇦🇺

Melbourne Health, Melbourne, Victoria, Australia

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

Not Applicable
Terminated
Conditions
Leukemia, Lymphoblastic, Acute
Lymphoblastic Leukemia, Acute, Childhood
Lymphoblastic Leukemia, Acute, L1
Cancer of Brain
Lymphocytic Leukemia, Acute
Lymphocytic Leukemia, L2
Cancer of the Brain
Malignant Primary Brain Tumors
Brain Neoplasms, Malignant
Leukemia, Lymphoblastic
Interventions
First Posted Date
2010-04-09
Last Posted Date
2015-03-27
Lead Sponsor
University of Minnesota
Target Recruit Count
1
Registration Number
NCT01100658
Locations
🇺🇸

University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath